Valuation: ZIM Laboratories Limited

Market Cap 629.74Cr 6.57Cr 5.77Cr 5.38Cr 4.94Cr 9.27Cr 9.4Cr 64Cr 25Cr 310.82Cr 25Cr 24Cr 1.08TCr P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 716.04Cr 7.47Cr 6.57Cr 6.11Cr 5.62Cr 11Cr 11Cr 73Cr 28Cr 353.41Cr 28Cr 27Cr 1.22TCr EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.79%
Yield 2025 *
-
Yield 2026 -
1 day-2.00%
1 week-6.26%
Current month-5.39%
1 month-5.05%
3 months+40.77%
6 months+65.10%
Current year+63.58%
1 week 117.6
Extreme 117.6
122.5
1 month 111.5
Extreme 111.5
126.3
Current year 59.72
Extreme 59.72
133.95
1 year 59.72
Extreme 59.72
133.95
3 years 59.72
Extreme 59.72
151.75
5 years 36.37
Extreme 36.3667
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 01/01/2002
Director of Finance/CFO - 01/04/2019
Director of Finance/CFO - 01/01/1991
Director TitleAgeSince
Chairman - 01/01/1990
Director/Board Member - 01/01/1991
Director/Board Member - 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-6.26%+3.38%+3.75% 6.67Cr
+1.68%+2.13%+16.17%+77.49% 4.84TCr
+1.52%+2.95%+60.39%+112.28% 3.58TCr
-0.09%-0.66%-8.03%+31.90% 1.18TCr
-0.05%-3.10%+13.50%+77.95% 1.15TCr
-0.37%-0.37%+37.53%+142.08% 901.45Cr
+0.18%+0.58%+49.62%-9.13% 698.99Cr
+0.95%-2.00%+12.78%+32.58% 669.73Cr
+0.18%-1.77%+2.36%+172.36% 642.34Cr
+3.51%-10.57%-31.55%+0.09% 529.99Cr
Average +0.55%-1.52%+15.61%+64.14% 1.42TCr
Weighted average by Cap. +1.11%-0.15%+25.52%+81.59%

Financials

2025 2026
Net sales 379.13Cr 3.95Cr 3.48Cr 3.24Cr 2.97Cr 5.58Cr 5.66Cr 38Cr 15Cr 187.13Cr 15Cr 15Cr 647.45Cr 374.4Cr 3.9Cr 3.43Cr 3.2Cr 2.94Cr 5.51Cr 5.59Cr 38Cr 15Cr 184.79Cr 15Cr 14Cr 639.37Cr
Net income 12Cr 12.69L 11.15L 10.39L 10L 17.92L 18.15L 1.23Cr 48.21L 6Cr 47.62L 46.59L 21Cr 5.84Cr 6L 5L 5L 5L 9L 9L 59.12L 23.14L 2.88Cr 22.85L 22.36L 9.97Cr
Net Debt 115.76Cr 1.21Cr 1.06Cr 98.85L 90.83L 1.7Cr 1.73Cr 12Cr 4.59Cr 57Cr 4.53Cr 4.43Cr 197.69Cr 86Cr 90L 79.13L 73.7L 67.72L 1.27Cr 1.29Cr 8.74Cr 3.42Cr 43Cr 3.38Cr 3.31Cr 147.39Cr
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
27/26/27 ₹117.60 -2.00% 995
24/26/24 ₹120.00 -0.04% 2,214
23/26/23 ₹120.05 -2.00% 500
21/26/21 ₹122.50 -2.00% 400
  1. Stock Market
  2. Stocks
  3. ZIMLAB Stock